|
|
|
Size
|
1st conference of the International Society for Evidence-Based Health Care, New Delhi 7,8 October
|
Paul Glasziou |
Mon, 19 Mar 2012 11:45:23 +1000 |
213 lines |
2012 Successful Established Courses in Qualitative Evidence Synthesis and in Introduction to Systematic Reviews
|
Andrew Booth |
Fri, 30 Mar 2012 10:40:28 +0100 |
224 lines |
3-day EBM Workshop on the Gold Coast, May 2-4
|
Paul Glasziou |
Wed, 7 Mar 2012 17:08:16 +1000 |
470 lines |
|
joseph ana |
Sat, 3 Mar 2012 09:36:27 +0000 |
24 lines |
Re: Academic publishing
|
Amy Price |
Thu, 22 Mar 2012 20:09:08 -0400 |
1193 lines |
Re: Academic publishing
|
Mike Kronenfeld |
Thu, 22 Mar 2012 15:25:59 -0700 |
1161 lines |
Re: Academic publishing
|
Amy Price |
Thu, 22 Mar 2012 18:16:24 -0400 |
1080 lines |
Fwd: Academic publishing
|
Mike Kronenfeld |
Thu, 22 Mar 2012 14:48:35 -0700 |
1025 lines |
Re: Academic publishing
|
Amy Price |
Thu, 22 Mar 2012 17:35:49 -0400 |
992 lines |
Re: Academic publishing
|
Paul Elias |
Thu, 22 Mar 2012 06:03:27 -0700 |
789 lines |
Re: Academic publishing
|
Weyant, Robert J |
Thu, 22 Mar 2012 08:54:44 -0400 |
796 lines |
Re: Academic publishing
|
Anoop Balachandran |
Thu, 22 Mar 2012 07:42:11 -0500 |
796 lines |
Academic publishing
|
Suhail Doi |
Thu, 22 Mar 2012 22:03:20 +1000 |
217 lines |
Re: Academic Publishing
|
Jordan Panayotov |
Thu, 22 Mar 2012 01:53:57 +1100 |
343 lines |
Academic Publishing
|
Jordan Panayotov |
Wed, 21 Mar 2012 13:57:15 +1100 |
150 lines |
Re: Academic publishing - PLoS/HIFA2015 Webinar on Open Access and Healthcare Information in Low Income Countries, 28th March, 3pm UK time
|
Neil Pakenham-Walsh, UK |
Thu, 22 Mar 2012 14:16:56 +0000 |
1289 lines |
Assessing impact of evidence (evidence about EBM)
|
Matthew Williams |
Wed, 21 Mar 2012 16:17:39 +0000 |
41 lines |
change of email
|
Belén Calvo-Til |
Fri, 23 Mar 2012 09:05:42 +0000 |
40 lines |
Re: Clinical utility of the Cochrane reviews
|
manueli kavika |
Sun, 4 Mar 2012 23:47:06 +0000 |
91 lines |
Re: Clinical utility of the Cochrane reviews
|
Miranda Cumpston |
Mon, 5 Mar 2012 10:17:27 +1100 |
76 lines |
Clinical utility of the Cochrane reviews
|
Piersante Sestini |
Sat, 3 Mar 2012 23:37:48 +0100 |
26 lines |
Correction Re: Evidence based Integrative (Complimentary and Alternative Medicine) Medicine - Conference in Oman 2013
|
Kamlesh Bhargava |
Sat, 3 Mar 2012 22:33:35 +0400 |
187 lines |
CORRECTION: Re: Validated Critical Appraisal Tool
|
David P. Dillard |
Fri, 2 Mar 2012 12:44:02 -0500 |
286 lines |
Re: Cost of defensive medicine...
|
madhusree singh |
Mon, 26 Mar 2012 11:09:52 -0700 |
50 lines |
Re: Cost of defensive medicine...
|
Jim Walker |
Mon, 26 Mar 2012 11:32:44 -0400 |
130 lines |
Re: Cost of defensive medicine...
|
[log in to unmask] |
Mon, 26 Mar 2012 11:00:36 -0400 |
228 lines |
Re: Cost of defensive medicine...
|
Ash Paul |
Mon, 26 Mar 2012 07:33:53 -0700 |
160 lines |
Re: Cost of defensive medicine...
|
Jim Walker |
Mon, 26 Mar 2012 08:20:38 -0400 |
61 lines |
Cost of defensive medicine...
|
Djulbegovic, Benjamin |
Mon, 26 Mar 2012 11:47:51 +0000 |
20 lines |
Re: Critical Appraisal of RCTs Using "RAAMbo" acronym
|
Djulbegovic, Benjamin |
Wed, 28 Mar 2012 18:44:42 +0000 |
486 lines |
Re: Critical Appraisal of RCTs Using "RAAMbo" acronym
|
David Braunholtz |
Wed, 28 Mar 2012 12:53:44 +0100 |
193 lines |
Critical Appraisal of RCTs Using "RAAMbo" acronym
|
Ruwan Parakramawansha |
Tue, 27 Mar 2012 22:57:07 +0100 |
1058 lines |
Critical Appraisal of RCTs Using "RAAMbo" acronym
|
Ruwan Parakramawansha |
Tue, 27 Mar 2012 22:52:42 +0100 |
196 lines |
Don't miss the opportunity; The Extended Systematic Review Course is starting soon in Riyadh, Saudi Arabia
|
Lubna A. Al-Ansary |
Fri, 9 Mar 2012 15:18:55 -0800 |
27600 lines |
EQUATOR Scientific Symposium October 2012 (Date for your diary)
|
Shona Kirtley |
Thu, 8 Mar 2012 12:35:24 +0000 |
301 lines |
Evidence around structure of evidence? (PICO, etc.)
|
Matt Williams |
Mon, 19 Mar 2012 20:26:54 +0000 |
24 lines |
Re: Evidence based Integrative Medicine - Conference in Oman 2013
|
Paul Elias |
Sat, 3 Mar 2012 12:25:28 -0800 |
133 lines |
Re: Evidence based Integrative Medicine - Conference in Oman 2013
|
Paul Elias |
Sat, 3 Mar 2012 12:24:30 -0800 |
2342 lines |
Evidence based Integrative Medicine - Conference in Oman 2013
|
Kamlesh Bhargava |
Sat, 3 Mar 2012 21:23:26 +0400 |
86 lines |
Evidence Based Medicine: The Books
|
David P. Dillard |
Sun, 4 Mar 2012 20:24:54 -0500 |
137 lines |
evidence on EBHC
|
Dr. Carlos Cuello |
Sun, 25 Mar 2012 08:44:43 -0600 |
53 lines |
Re: Examples of the wonderful "innovations argument from the European Society of Cardiology
|
Amy Price |
Thu, 15 Mar 2012 23:42:24 -0400 |
167 lines |
Examples of the wonderful "innovations argument from the European Society of Cardiology
|
Poses, Roy |
Wed, 14 Mar 2012 12:23:52 -0400 |
105 lines |
Re: Exporting from SIGLE?
|
Andrzej Glowinski |
Wed, 28 Mar 2012 21:36:41 +0100 |
174 lines |
Re: Exporting from SIGLE?
|
Susan Fowler |
Wed, 28 Mar 2012 14:07:39 -0500 |
100 lines |
Re: Exporting from SIGLE?
|
k.hopayian |
Wed, 28 Mar 2012 20:00:35 +0100 |
147 lines |
Re: Exporting from SIGLE?
|
William Grant |
Wed, 28 Mar 2012 14:46:53 -0400 |
128 lines |
Exporting from SIGLE?
|
Susan Fowler |
Wed, 28 Mar 2012 13:06:47 -0500 |
50 lines |
Re: Finding the Hard to Finds: and the odd virus
|
jo kirkpatrick |
Fri, 16 Mar 2012 19:55:27 +0000 |
220 lines |
Finding the Hard to Finds: and the odd virus
|
Weyant, Robert J |
Fri, 16 Mar 2012 13:35:54 -0400 |
230 lines |
Re: Finding the Hard to Finds: and the odd virus
|
Dean Giustini |
Fri, 16 Mar 2012 10:21:11 -0700 |
233 lines |
Re: Finding the Hard to Finds: and the odd virus
|
jo kirkpatrick |
Fri, 16 Mar 2012 17:00:00 +0000 |
157 lines |
Re: Finding the Hard to Finds: Searching for Grey Literature
|
David P. Dillard |
Thu, 15 Mar 2012 06:34:59 -0400 |
229 lines |
Re: Finding the Hard to Finds: Searching for Grey Literature
|
Susan Fowler |
Wed, 14 Mar 2012 16:53:43 -0500 |
106 lines |
Finding the Hard to Finds: Searching for Grey Literature
|
Ash Paul |
Wed, 14 Mar 2012 14:41:52 -0700 |
34 lines |
framework analysis, qualitative data, policy, patient experience
|
KATE BLOOR |
Fri, 9 Mar 2012 18:03:35 +0000 |
33 lines |
French translation of CEBM Levels of Evidence
|
Jeremy Howick |
Thu, 8 Mar 2012 16:31:48 +0000 |
46 lines |
Re: Fruits & Vegetable Supplement
|
jo kirkpatrick |
Sun, 11 Mar 2012 00:52:39 +0000 |
117 lines |
Re: Fruits & Vegetable Supplement
|
Joseph Matthews |
Fri, 9 Mar 2012 16:52:08 -0700 |
211 lines |
Fruits & Vegetable Supplement
|
Anoop Balachandran |
Fri, 9 Mar 2012 13:39:47 +0000 |
44 lines |
Re: Guide to Using Twitter in University Research, Teaching, and Impact Activities
|
Ash Paul |
Mon, 26 Mar 2012 14:12:28 -0700 |
28960 lines |
Re: Health Statistics Users Group, Meeting on Developments in Data Linkage, Leeds, March 29
|
Macfarlane, Alison |
Mon, 12 Mar 2012 16:49:17 +0000 |
232 lines |
Re: Health Statistics Users Group, Meeting on Developments in Data Linkage, Leeds, March 29
|
Macfarlane, Alison |
Mon, 12 Mar 2012 16:41:48 +0000 |
197 lines |
Re: hiru mcmaster thru BMJ evidence updates is most efficient way of finding new treatments
|
Paul Glasziou |
Wed, 7 Mar 2012 17:13:48 +1000 |
78 lines |
hiru mcmaster thru BMJ evidence updates is most efficient way of finding new treatments
|
Bruce Arroll |
Wed, 7 Mar 2012 07:04:10 +0000 |
38 lines |
History and Philosophy of EBM: new course at Oxford!
|
Jeremy Howick |
Wed, 7 Mar 2012 10:57:55 +0000 |
251 lines |
Re: how to design the study
|
jo kirkpatrick |
Thu, 8 Mar 2012 12:37:09 +0000 |
104 lines |
how to design the study
|
ya dev |
Wed, 7 Mar 2012 01:55:17 +0530 |
31 lines |
How to Practise Evidence-Based Child Health, 13-15 June
|
Pribramska, Ivana |
Tue, 13 Mar 2012 14:20:50 +0000 |
332 lines |
Improving the Effectiveness of Clinical Medicine: The Need for Better Science
|
Ash Paul |
Mon, 19 Mar 2012 07:20:48 -0700 |
56 lines |
Re: Interpretation of hazard ratios
|
jo kirkpatrick |
Wed, 14 Mar 2012 20:09:03 +0000 |
625 lines |
Re: Interpretation of hazard ratios
|
Ahmed Abou-Setta, M.D. |
Wed, 14 Mar 2012 13:56:41 -0500 |
981 lines |
Re: Interpretation of hazard ratios
|
jo kirkpatrick |
Wed, 14 Mar 2012 18:19:10 +0000 |
382 lines |
Re: Interpretation of hazard ratios
|
Paul Elias |
Wed, 14 Mar 2012 08:07:33 -0700 |
377 lines |
Re: Interpretation of hazard ratios
|
jo kirkpatrick |
Wed, 14 Mar 2012 14:21:40 +0000 |
281 lines |
Re: Interpretation of hazard ratios
|
Paul Elias |
Wed, 14 Mar 2012 06:20:06 -0700 |
262 lines |
Re: Interpretation of hazard ratios
|
jo kirkpatrick |
Wed, 14 Mar 2012 12:49:03 +0000 |
632 lines |
Re: Interpretation of hazard ratios
|
Ted Harding |
Wed, 14 Mar 2012 09:57:00 -0000 |
85 lines |
Interpretation of hazard ratios
|
Jenny Morris |
Wed, 14 Mar 2012 09:08:24 +0000 |
220 lines |
Re: journal watch/scanning services
|
Jon Brassey |
Wed, 7 Mar 2012 07:24:01 +0000 |
98 lines |
Re: journal watch/scanning services
|
Catherine Voutier |
Wed, 7 Mar 2012 06:21:40 +0000 |
23 lines |
Re: journal watch/scanning services
|
Richard Hockey |
Mon, 5 Mar 2012 23:33:07 +0000 |
208 lines |
Re: journal watch/scanning services
|
Dr. Carlos Cuello |
Mon, 5 Mar 2012 16:12:07 -0600 |
331 lines |
Re: journal watch/scanning services
|
Simon Hatcher |
Mon, 5 Mar 2012 21:35:25 +0000 |
264 lines |
Re: journal watch/scanning services
|
Dr. Amy Price |
Mon, 5 Mar 2012 09:47:21 -0500 |
250 lines |
Re: journal watch/scanning services
|
Richard Saitz |
Mon, 5 Mar 2012 08:57:11 -0500 |
237 lines |
Re: journal watch/scanning services
|
Douglas Badenoch |
Mon, 5 Mar 2012 10:29:49 +0000 |
289 lines |
Re: journal watch/scanning services
|
David P. Dillard |
Sun, 4 Mar 2012 22:04:23 -0500 |
203 lines |
journal watch/scanning services
|
Tammy Hoffmann |
Mon, 5 Mar 2012 12:34:57 +1000 |
222 lines |
Re: keep 'em coming...RE: Top 3 (or so) essential clinical epi concepts
|
Bewley, Susan |
Mon, 12 Mar 2012 16:29:05 +0000 |
138 lines |
Re: keep 'em coming...RE: Top 3 (or so) essential clinical epi concepts
|
Mayer, Dan |
Sun, 11 Mar 2012 10:20:27 -0400 |
77 lines |
Re: keep 'em coming...RE: Top 3 (or so) essential clinical epi concepts
|
[log in to unmask] |
Sun, 11 Mar 2012 09:51:04 -0400 |
136 lines |
Re: keep 'em coming...RE: Top 3 (or so) essential clinical epi concepts
|
Emily DeVoto |
Sun, 11 Mar 2012 13:34:19 +0000 |
273 lines |
keep 'em coming...RE: Top 3 (or so) essential clinical epi concepts
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Sun, 11 Mar 2012 09:10:58 -0400 |
115 lines |
Re: lead time error
|
Richard Saitz |
Mon, 5 Mar 2012 15:22:52 -0500 |
583 lines |
Re: lead time error
|
Richard Saitz |
Mon, 5 Mar 2012 10:40:20 -0500 |
305 lines |
leave list
|
Carla Morganti |
Sat, 3 Mar 2012 20:11:29 +0100 |
474 lines |
leave list
|
[log in to unmask] |
Fri, 2 Mar 2012 19:01:30 +0000 |
12 lines |
Lessons from Europe: Does tariff re-design drive value in health care? 26 April, London
|
HSRN |
Fri, 9 Mar 2012 14:03:21 -0000 |
595 lines |
Re: Medication in elderly
|
Anne Teichman |
Wed, 28 Mar 2012 12:08:18 -0700 |
94 lines |
Medication in elderly
|
Davorka Vrdoljak |
Wed, 28 Mar 2012 10:25:55 +0200 |
31 lines |
Re: medicines heathcare products regulatory authority Q's about transparency
|
Ash Paul |
Sun, 4 Mar 2012 17:36:53 -0800 |
386 lines |
Re: medicines heathcare products regulatory authority Q's about transparency
|
Douglas Badenoch |
Sun, 4 Mar 2012 11:14:26 +0000 |
95 lines |
Re: medicines heathcare products regulatory authority Q's about transparency
|
Faulkner, Alex |
Sat, 3 Mar 2012 13:17:48 +0000 |
94 lines |
medicines heathcare products regulatory authority Q's about transparency
|
KATE BLOOR |
Sat, 3 Mar 2012 12:23:19 +0000 |
105 lines |
New Persian EBM website
|
Sakineh Hajebrahimi |
Mon, 19 Mar 2012 12:22:19 +0330 |
55 lines |
Re: online M.Sc. in Clinical Epidemiology
|
Geert van der Heijden |
Mon, 26 Mar 2012 16:43:26 +0100 |
34 lines |
online M.Sc. in Clinical Epidemiology
|
สงวนศักดิ์ ธ |
Tue, 20 Mar 2012 12:51:16 +0700 |
20 lines |
Open access, Evidence-Based Health and Systematic Reviews
|
Neil Pakenham-Walsh, UK |
Fri, 23 Mar 2012 10:05:50 +0000 |
146 lines |
PEARLS
|
Bruce Arroll |
Tue, 6 Mar 2012 04:09:46 +0000 |
607 lines |
Re: Peer-reviewing literature search strategies
|
Ahmed M. Abou-Setta, M.D. |
Wed, 7 Mar 2012 05:42:37 -0600 |
451 lines |
Re: Peer-reviewing literature search strategies
|
Ahmed M. Abou-Setta, M.D. |
Wed, 7 Mar 2012 05:40:48 -0600 |
325 lines |
Re: Peer-reviewing literature search strategies
|
Stewart, Fiona |
Wed, 7 Mar 2012 09:31:41 +0000 |
373 lines |
Re: Peer-reviewing literature search strategies
|
Julie Glanville |
Wed, 7 Mar 2012 09:33:21 +0000 |
187 lines |
Peer-reviewing literature search strategies
|
Ahmed M. Abou-Setta, M.D. |
Wed, 7 Mar 2012 03:21:48 -0600 |
139 lines |
Re: Perils of open access
|
Steve Simon, P.Mean Consulting |
Mon, 26 Mar 2012 13:41:13 -0500 |
45 lines |
Re: Perils of open access
|
Suhail Doi |
Mon, 26 Mar 2012 22:01:45 +1000 |
89 lines |
Re: Perils of open access
|
Ahmed M. Abou-Setta, MD |
Mon, 26 Mar 2012 06:48:05 -0500 |
731 lines |
Re: Perils of open access
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Mon, 26 Mar 2012 07:31:57 -0400 |
157 lines |
Re: Perils of open access
|
Neil Pakenham-Walsh, UK |
Mon, 26 Mar 2012 10:27:39 +0100 |
388 lines |
Re: Perils of open access
|
Trish Groves |
Mon, 26 Mar 2012 08:34:08 +0100 |
130 lines |
Re: Perils of open access
|
Richard Hockey |
Mon, 26 Mar 2012 05:10:08 +0000 |
76 lines |
Re: Perils of open access
|
Ahmed M. Abou-Setta, MD |
Sun, 25 Mar 2012 23:55:48 -0500 |
105 lines |
Re: Perils of open access
|
Amy Price |
Mon, 26 Mar 2012 00:47:58 -0400 |
78 lines |
Re: Perils of open access
|
Steve Simon, P.Mean Consulting |
Sun, 25 Mar 2012 23:22:23 -0500 |
67 lines |
Re: Perils of open access
|
Suhail Doi |
Mon, 26 Mar 2012 09:11:05 +1000 |
158 lines |
Re: Perils of open access
|
Suhail Doi |
Mon, 26 Mar 2012 08:42:16 +1000 |
155 lines |
Re: Perils of open access
|
Lehman, Richard |
Sun, 25 Mar 2012 15:06:39 +0000 |
472 lines |
Re: Perils of open access
|
Ash Paul |
Sun, 25 Mar 2012 07:52:02 -0700 |
260 lines |
Re: Perils of open access
|
Lehman, Richard |
Sun, 25 Mar 2012 14:41:46 +0000 |
144 lines |
Re: Perils of open access
|
Ash Paul |
Sun, 25 Mar 2012 07:22:03 -0700 |
177 lines |
Re: Perils of open access
|
Amy Price |
Sun, 25 Mar 2012 10:18:21 -0400 |
130 lines |
Re: Perils of open access
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Sun, 25 Mar 2012 09:49:18 -0400 |
116 lines |
Re: Perils of open access
|
Richard Saitz |
Sun, 25 Mar 2012 07:40:03 -0400 |
91 lines |
Re: Perils of open access
|
Ginny Barbour |
Sun, 25 Mar 2012 09:23:37 +0100 |
37 lines |
Re: Perils of open access
|
Rakesh Biswas |
Sun, 25 Mar 2012 08:25:38 +0530 |
266 lines |
Re: Perils of open access
|
Neil Pakenham-Walsh, UK |
Sat, 24 Mar 2012 21:08:25 +0000 |
205 lines |
Re: Perils of open access
|
k.hopayian |
Sat, 24 Mar 2012 15:46:51 +0000 |
44 lines |
Re: Perils of open access
|
Suhail Doi |
Sat, 24 Mar 2012 10:17:16 +1000 |
40 lines |
Re: Perils of open access
|
Jacob Puliyel |
Fri, 23 Mar 2012 22:54:22 +0530 |
140 lines |
Re: Perils of open access
|
Ahmed Abou-Setta, M.D. |
Fri, 23 Mar 2012 10:47:23 -0500 |
558 lines |
Re: Perils of open access
|
Ahmed Abou-Setta, M.D. |
Fri, 23 Mar 2012 10:43:15 -0500 |
492 lines |
Re: Perils of open access
|
Dr. Carlos Cuello |
Fri, 23 Mar 2012 09:03:02 -0600 |
176 lines |
Re: Perils of open access
|
Susan Fowler |
Fri, 23 Mar 2012 09:32:08 -0500 |
217 lines |
Re: Perils of open access
|
Joy MacDermid |
Fri, 23 Mar 2012 13:47:43 +0000 |
74 lines |
Re: Perils of open access
|
Suhail Doi |
Fri, 23 Mar 2012 23:40:57 +1000 |
220 lines |
Re: Perils of open access
|
Susan Fowler |
Fri, 23 Mar 2012 08:29:38 -0500 |
119 lines |
Re: Perils of open access
|
Suhail Doi |
Fri, 23 Mar 2012 23:01:02 +1000 |
21 lines |
Re: Perils of open access
|
Suhail Doi |
Fri, 23 Mar 2012 17:02:31 +1000 |
38 lines |
Re: Perils of open access
|
Amy Price |
Thu, 22 Mar 2012 21:45:06 -0400 |
76 lines |
Perils of open access
|
Suhail Doi |
Fri, 23 Mar 2012 11:19:06 +1000 |
57 lines |
Re: Perils of open access - some OA journals offer fee waivers
|
Richard Saitz |
Fri, 23 Mar 2012 10:30:14 -0400 |
927 lines |
Re: Perils of open access - some OA journals offer fee waivers
|
Trish Groves |
Fri, 23 Mar 2012 14:01:55 +0000 |
508 lines |
Re: Perils of open accessht
|
Tamara Melnik |
Fri, 23 Mar 2012 14:02:32 -0300 |
392 lines |
Please don't post attachments to the list.
|
Douglas Badenoch |
Wed, 28 Mar 2012 09:24:03 +0100 |
40 lines |
Please unsubscribe
|
Rush, Jessica |
Mon, 5 Mar 2012 08:54:39 -0600 |
372 lines |
Re: Qualitative Health research sources?
|
David P. Dillard |
Mon, 5 Mar 2012 02:23:57 -0500 |
758 lines |
Qualitative Health research sources?
|
Salman Shafiq |
Sun, 4 Mar 2012 00:19:09 -0800 |
99 lines |
Qualitative Resaerch Methods courses at University of Oxford
|
Jenny Hislop |
Mon, 5 Mar 2012 13:02:01 +0000 |
264 lines |
Re: questionnaire validation
|
jo kirkpatrick |
Wed, 7 Mar 2012 20:51:20 +0000 |
100 lines |
Re: questionnaire validation
|
Rod O'Connor |
Wed, 7 Mar 2012 20:17:04 +1100 |
254 lines |
Re: questionnaire validation
|
Steve Simon, P.Mean Consulting |
Tue, 6 Mar 2012 12:33:19 -0600 |
41 lines |
Re: questionnaire validation
|
William Grant |
Tue, 6 Mar 2012 08:23:21 -0500 |
111 lines |
questionnaire validation
|
Michael Bennett |
Tue, 6 Mar 2012 06:48:00 +0000 |
66 lines |
Re: R: Clinical utility of the Cochrane reviews
|
Piersante Sestini |
Sun, 4 Mar 2012 21:28:35 +0100 |
272 lines |
Re: R: Clinical utility of the Cochrane reviews
|
Hugh McGuire |
Sun, 4 Mar 2012 20:22:08 -0000 |
138 lines |
Re: R: Clinical utility of the Cochrane reviews
|
Evan Mayo-Wilson |
Sun, 4 Mar 2012 20:02:18 +0000 |
205 lines |
Re: R: Clinical utility of the Cochrane reviews
|
Paul Elias |
Sun, 4 Mar 2012 11:23:11 -0800 |
128 lines |
R: Clinical utility of the Cochrane reviews
|
Nino Cartabellotta |
Sun, 4 Mar 2012 11:00:19 -0800 |
30 lines |
R: lead time error
|
Barbani Federico |
Mon, 5 Mar 2012 18:28:07 +0100 |
408 lines |
R: Medication in elderly
|
Felice Musicco (IFO) |
Wed, 28 Mar 2012 11:04:38 +0200 |
92 lines |
Read the latest issue of Journal of Public Mental Health
|
Mary Miskin |
Mon, 19 Mar 2012 15:12:56 +0000 |
349 lines |
Re: Red Meat Consumption and Mortality
|
Anoop Balachandran |
Tue, 27 Mar 2012 13:16:18 -0500 |
150 lines |
Re: Red Meat Consumption and Mortality
|
Ash Paul |
Sun, 25 Mar 2012 15:03:33 -0700 |
84 lines |
Re: Red Meat Consumption and Mortality
|
Yaser Adi |
Mon, 26 Mar 2012 00:42:02 +0300 |
32 lines |
Re: Red Meat Consumption and Mortality
|
Yaser Adi |
Mon, 26 Mar 2012 00:26:37 +0300 |
148 lines |
Re: Red Meat Consumption and Mortality
|
Ash Paul |
Sun, 25 Mar 2012 06:49:15 -0700 |
92 lines |
Re: Red Meat Consumption and Mortality
|
Rod Jackson |
Sun, 25 Mar 2012 06:25:32 +0000 |
46 lines |
Red Meat Consumption and Mortality
|
Anoop Balachandran |
Sat, 24 Mar 2012 15:17:19 +0000 |
21 lines |
Registrations now open!! Transforming Information Services in a Changing HTA Environment - Bilbao Spain 24th June 2012
|
Catherine Voutier |
Tue, 20 Mar 2012 22:18:42 +0000 |
61 lines |
regulation of medical devices - MHRA
|
KATE BLOOR |
Mon, 5 Mar 2012 19:48:12 +0000 |
51 lines |
researchers don't read journals?
|
Dr Adrian Midgley (At work at Isca medical Practice) |
Thu, 22 Mar 2012 18:26:24 +0000 |
15 lines |
Re: Secondary vs. tertiary outcomes?
|
Stephanie Chan |
Wed, 29 Feb 2012 16:53:14 -0800 |
715 lines |
Re: Secondary vs. tertiary outcomes?
|
Djulbegovic, Benjamin |
Thu, 1 Mar 2012 00:37:13 +0000 |
582 lines |
Sign off
|
Anne Treimer |
Fri, 23 Mar 2012 18:58:34 +0100 |
27 lines |
Re: sneezing into the elbow
|
jo kirkpatrick |
Fri, 2 Mar 2012 21:46:31 +0000 |
286 lines |
Re: sneezing into the elbow
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Fri, 2 Mar 2012 15:55:11 -0500 |
236 lines |
Re: sneezing into the elbow
|
Bill Cayley, Jr |
Fri, 2 Mar 2012 12:53:42 -0800 |
326 lines |
Re: sneezing into the elbow
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Fri, 2 Mar 2012 15:36:06 -0500 |
185 lines |
Re: sneezing into the elbow
|
jo kirkpatrick |
Fri, 2 Mar 2012 20:30:58 +0000 |
219 lines |
Re: sneezing into the elbow
|
Susan Fowler |
Fri, 2 Mar 2012 13:13:49 -0600 |
303 lines |
Re: sneezing into the elbow
|
madhusree singh |
Fri, 2 Mar 2012 11:21:02 -0800 |
23 lines |
Re: sneezing into the elbow
|
Patricia F. Anderson |
Fri, 2 Mar 2012 13:41:47 -0500 |
341 lines |
Re: sneezing into the elbow
|
Bill Cayley, Jr |
Fri, 2 Mar 2012 10:45:50 -0800 |
258 lines |
Re: sneezing into the elbow
|
Dawes, Martin |
Fri, 2 Mar 2012 10:32:48 -0800 |
132 lines |
Re: sneezing into the elbow
|
Andy Hutchinson |
Fri, 2 Mar 2012 17:11:10 +0000 |
110 lines |
Re: sneezing into the elbow
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Fri, 2 Mar 2012 12:09:09 -0500 |
57 lines |
Re: sneezing into the elbow
|
Alligood, Elaine C |
Fri, 2 Mar 2012 12:06:34 -0500 |
62 lines |
sneezing into the elbow
|
Dawes, Martin |
Fri, 2 Mar 2012 08:56:31 -0800 |
33 lines |
Re: FW: sneezing into the elbow - the Dracula sneeze
|
James D Grant MD, FACEP.Facp |
Fri, 2 Mar 2012 17:34:41 -0500 |
69 lines |
Re: FW: sneezing into the elbow - the Dracula sneeze
|
Liliana Laranjo |
Fri, 2 Mar 2012 22:07:01 +0000 |
126 lines |
Re: FW: sneezing into the elbow - the Dracula sneeze
|
jo kirkpatrick |
Fri, 2 Mar 2012 22:03:05 +0000 |
80 lines |
Re: sneezing into the elbow - the Dracula sneeze
|
jo kirkpatrick |
Fri, 2 Mar 2012 21:54:57 +0000 |
372 lines |
Re: FW: sneezing into the elbow - the Dracula sneeze
|
Ted Harding |
Fri, 2 Mar 2012 21:14:50 -0000 |
44 lines |
Re: sneezing into the elbow - the Dracula sneeze
|
Bill Cayley, Jr |
Fri, 2 Mar 2012 12:55:12 -0800 |
396 lines |
FW: sneezing into the elbow - the Dracula sneeze
|
Campbell, Sandy |
Fri, 2 Mar 2012 13:38:05 -0700 |
477 lines |
Society for Social Medicine: Abstract deadline 19th March + other conferences of interest
|
Martin White |
Fri, 16 Mar 2012 11:17:02 +0000 |
265 lines |
Re: Statistical question
|
Underwood, Frank |
Tue, 13 Mar 2012 13:59:45 +0000 |
1424 lines |
Re: Statistical question
|
Watkeys Jacqui (RBK) Walsall Healthcare NHS UK |
Tue, 13 Mar 2012 12:27:19 -0000 |
1840 lines |
Re: Statistical question
|
Ahmed M. Abou-Setta, MD |
Tue, 13 Mar 2012 07:25:22 -0500 |
1072 lines |
Re: Statistical question
|
s alhabib |
Tue, 13 Mar 2012 04:36:22 -0700 |
396 lines |
Statistical question
|
Watkeys Jacqui (RBK) Walsall Healthcare NHS UK |
Tue, 13 Mar 2012 10:02:55 -0000 |
628 lines |
Re: Surrogate Measure Question
|
Anoop Balachandran |
Mon, 5 Mar 2012 20:20:48 -0600 |
146 lines |
Re: Surrogate Measure Question
|
Stephanie Chan |
Mon, 5 Mar 2012 11:21:29 -0800 |
103 lines |
Surrogate Measure Question
|
Anoop Balachandran |
Mon, 5 Mar 2012 18:58:19 +0000 |
26 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Paul Elias |
Mon, 5 Mar 2012 09:09:57 -0800 |
349 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Richard Saitz |
Mon, 5 Mar 2012 11:16:44 -0500 |
623 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Richard Saitz |
Mon, 5 Mar 2012 10:56:28 -0500 |
373 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Piersante Sestini |
Mon, 5 Mar 2012 15:34:35 +0100 |
248 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Richard Saitz |
Mon, 5 Mar 2012 08:32:30 -0500 |
767 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Dr. Carlos Cuello |
Mon, 5 Mar 2012 07:16:22 -0600 |
408 lines |
Re: Sv: Re: Clinical utility of the Cochrane reviews
|
Paul Elias |
Mon, 5 Mar 2012 04:43:51 -0800 |
274 lines |
Sv: Re: Clinical utility of the Cochrane reviews
|
[log in to unmask] |
Mon, 5 Mar 2012 09:09:01 +0100 |
101 lines |
Re: Systematic Reviewer/Research Fellow - Grade 7 - University of Birmingham
|
Susan Fowler |
Thu, 1 Mar 2012 10:32:35 -0600 |
289 lines |
The Dracula sneeze and Frankenstein's Monster
|
Neal Maskrey |
Sat, 3 Mar 2012 08:21:39 +0000 |
306 lines |
Re: The New Therapeutics: 10 Commandments
|
Ash Paul |
Sun, 25 Mar 2012 07:41:51 -0700 |
392 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Steve Simon, P.Mean Consulting |
Tue, 13 Mar 2012 11:07:24 -0500 |
43 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Andy Hutchinson |
Sun, 11 Mar 2012 22:06:29 +0000 |
161 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Cristian Baicus |
Sun, 11 Mar 2012 19:25:01 +0200 |
106 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Andy Hutchinson |
Sun, 11 Mar 2012 17:22:27 +0000 |
92 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Paul Elias |
Sun, 11 Mar 2012 08:37:03 -0700 |
119 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Dahm,Philipp |
Sun, 11 Mar 2012 15:33:10 +0000 |
42 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Rod Jackson |
Sun, 11 Mar 2012 00:20:36 +0000 |
245 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Fell Greg |
Sat, 10 Mar 2012 18:03:40 -0000 |
204 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Tom Jefferson |
Sat, 10 Mar 2012 18:39:48 +0100 |
122 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Michael Power |
Sat, 10 Mar 2012 17:34:58 -0000 |
45 lines |
Re: Top 3 (or so) essential clinical epi concepts
|
Bill |
Sat, 10 Mar 2012 11:08:54 -0600 |
55 lines |
Top 3 (or so) essential clinical epi concepts
|
Bastian, Hilda (NIH/NLM/NCBI) [C] |
Sat, 10 Mar 2012 11:25:20 -0500 |
29 lines |
TRACT listed in WHO Compendium of new and emerging health technologies
|
David Cawthorpe |
Sun, 18 Mar 2012 10:48:20 -0600 |
76 lines |
UK: ATLAS.ti and NVivo workshops
|
Silvana di Gregorio |
Thu, 15 Mar 2012 09:44:05 +0000 |
81 lines |
unsubscribe
|
Thompson, Laura |
Fri, 23 Mar 2012 09:55:09 -0400 |
200 lines |
UNSUBSCRIBE PLEASE FROM GROUP EMAILS
|
Shahrzad Roohy Gohar |
Wed, 28 Mar 2012 08:55:09 +1000 |
199 lines |
Re: Validated Critical Appraisal Tool
|
manueli kavika |
Sun, 4 Mar 2012 22:22:15 +0000 |
299 lines |
Re: Validated Critical Appraisal Tool
|
s alhabib |
Sat, 3 Mar 2012 12:43:20 -0800 |
116 lines |
Re: Validated Critical Appraisal Tool
|
David P. Dillard |
Fri, 2 Mar 2012 12:37:41 -0500 |
264 lines |
Re: Validated Critical Appraisal Tool
|
Jenny Morris |
Fri, 2 Mar 2012 08:22:58 +0000 |
66 lines |
Re: Validated Critical Appraisal Tool
|
manueli kavika |
Fri, 2 Mar 2012 00:24:38 +0000 |
234 lines |
Re: Validated Critical Appraisal Tool
|
Rod Jackson |
Thu, 1 Mar 2012 23:00:43 +0000 |
168 lines |
Validated Critical Appraisal Tool
|
Paula Bennett |
Thu, 1 Mar 2012 11:59:27 +0000 |
61 lines |
Validating critical evaluation tools?
|
Carol Perryman |
Fri, 23 Mar 2012 19:35:00 -0500 |
91 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Amy Price |
Thu, 15 Mar 2012 23:51:50 -0400 |
454 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Soraya Assar |
Thu, 15 Mar 2012 19:39:23 +0000 |
625 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Poses, Roy |
Thu, 15 Mar 2012 12:39:09 -0400 |
317 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Steve Simon, P.Mean Consulting |
Thu, 15 Mar 2012 11:23:49 -0500 |
113 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Ash Paul |
Wed, 14 Mar 2012 14:57:10 -0700 |
292 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
jo kirkpatrick |
Wed, 14 Mar 2012 21:16:22 +0000 |
312 lines |
Fwd: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Poses, Roy |
Wed, 14 Mar 2012 12:25:59 -0400 |
422 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Dr. Amy Price |
Tue, 13 Mar 2012 20:16:07 -0400 |
426 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Fell Greg |
Tue, 13 Mar 2012 21:09:58 -0000 |
183 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Poses, Roy |
Tue, 13 Mar 2012 16:23:23 -0400 |
272 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Neal Maskrey |
Tue, 13 Mar 2012 20:21:16 +0000 |
312 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Lehman, Richard |
Tue, 13 Mar 2012 20:10:21 +0000 |
340 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Christian Lerch |
Tue, 13 Mar 2012 21:09:02 +0100 |
133 lines |
Re: Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Neal Maskrey |
Tue, 13 Mar 2012 19:46:50 +0000 |
207 lines |
Wonderful "innovations" in an era of commercialized health care - what is the evidence?
|
Poses, Roy |
Tue, 13 Mar 2012 15:29:46 -0400 |
134 lines |
Workshop - Systematic Review and Meta-analysis of Direct, Indirect and Mixed Treatment Evidence, Glasgow
|
Olivia Wu |
Thu, 1 Mar 2012 09:26:22 +0000 |
44 lines |
Re: [Spam] Academic Publishing
|
Piersante Sestini |
Wed, 21 Mar 2012 08:58:57 +0100 |
154 lines |